Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Exp Hematol. 2011 Oct 21;40(2):131–142.e4. doi: 10.1016/j.exphem.2011.10.006

Fig. 5.

Fig. 5

p53−/− platelets are less sensitive to PAR-4 agonist-induced fibrinogen binding in vitro. % of maximal binding to fluorescently-conjugated fibrinogen by p53+/+ and p53−/− platelets under a range of AYPGKF concentrations assayed by flow cytometry. N=5. Error bars: SEM. Statistical analysis was conducted using a 2-tailed paired Student t-test; • indicates P = 0.01.